DiaCarta and Capstone Well being Alliance collaborate to develop revolutionary diagnostic assessments to enhance affected person care

DiaCarta and Capstone Well being Alliance collaborate to develop revolutionary diagnostic assessments to enhance affected person care



July 9, 2024 – DiaCarta, Inc. (“DiaCarta”) has entered right into a strategic collaboration with Capstone Well being Alliance. This new collaboration brings collectively highly effective applied sciences to enhance affected person care. DiaCarta’s core product portfolio contains the groundbreaking RadTox™ check, a blood check that screens tumor response and development following most cancers therapy by monitoring adjustments in cell-free circulating DNA (cfDNA) ranges. This serves to personalize radiation and chemotherapy, cut back unwanted side effects, and enhance affected person care. The State of Florida has applied the RadTox™ check statewide to be run between radiation or chemotherapy doses for real-time detection of therapy response or resistance.

The Oncuria Bladder Most cancers Exams are designed to detect bladder most cancers, monitor bladder most cancers recurrence, and revolutionize the prediction of BCG remedy response for sufferers with non-muscle invasive bladder most cancers (NMIBC), offering clinicians with personalised therapy methods. The VEXAS Syndrome Take a look at is a breakthrough, extremely delicate check used to diagnose a uncommon autoimmune illness that causes body-wide irritation as a result of a mutation within the UBA1 gene. The ColoScape™ Colorectal Most cancers Mutation Detection Blood Take a look at detects methylations which are extremely particular for CRC and related genetic mutations with excessive sensitivity for superior adenomas.

Discover out extra

Leave a Reply

Your email address will not be published. Required fields are marked *